Steinert myotonic dystrophy – a multisystemic disorder with occular implication by Costea, Claudia F. & Petraru, D.
 
 
 
Romanian Neurosurgery (2013) XX 3: 293 – 296          293 
 
 
 
Steinert myotonic dystrophy – a multisystemic disorder with 
occular implication 
Claudia F. Costea1, D. Petraru2 
“Grigore T. Popa” University of Medicine and Pharmacy of Iaşi 
Faculty of Dental Medicine  
1,22nd Clinic of Ophthalmology 
“Prof. Nicolae Oblu” Emergency Hospital of Iaşi 
 
Abstract 
The Steinert Myotonic Dystrophy is the 
most common systemic disease in adults 
with dominant autosomal transmission. We 
present two patients, who were hospitalized 
in the 2nd Clinic of Ophthalmology, at the 
"Prof. Nicolae Oblu" Emergency Hospital 
of Iasi, with the diagnosis of Pathological 
Cataract and Steinert Myotonic Dystrophy. 
Key words: Steinert myotonic dystrophy, 
pathologic cataract, palpebral ptosis. 
Introduction 
Myotonic Dystrophy is the most 
common dystrophy in adults, it is an 
autosomal dominant disease with two 
distinct genetic types: type 1 – the classical 
form described by Steinert and type 2 
identified by Ricker (1). The Steinert 
disease or type 1 myotonic dystrophy is a 
multisystem genetic disease that affects 
muscles (delayed muscle relaxation), 
nervous system, eyes and heart (2). The 
main ocular manifestations of the disease 
are: pathological cataract, myogenic 
palpebral ptosis (3) and reticular 
retinopathy. Cataract associated with 
Steinert disease have a pathognomonic 
aspect: the crystalline lens cortex shows 
polychromatic iridescent crystals formed 
from lens fiber plasmolemma (3). 
We present two clinical cases: A.A., aged 
51 years, A.E., 58, siblings diagnosed with 
Pathological Cataract Bilateral, Myogenic 
Ptosis grade 2-3 and Steinert Myotonic 
Dystrophy. 
Case 1 
Patient A.A., female,  51 years, from Iasi, 
comes for the symptoms: L.E. gradual 
decrease of visual acuity and palpebral 
ptosis. Medical history: R.E. operated 
pathological cataract (10 years ago), O.U. 
Myogenic Bilateral Ptosis, Steinert 
Myotonic Dystrophy. Local ocular 
examination: O.U. grade 2-3 ptosis (Figure 
1). Biomicroscopy examination highlights: 
R.E. pseudophakia, L.E. anterior and 
posterior cortical and nuclear subcapsular 
opacities; nucleus sclerosis +3; crystalline 
with a pathognomonic aspect, iridescent 
crystals in the cortex and nucleus. 
V.A.R.E. 1/500, V.A.L.E. 3/500, 
Ophthalmoscopic examination: R.E. - pale 
papilla, narrowed vessels with central 
emergence, macula with pigment 
dispersion; L.E. cannot be examined, due to 
lens opacification. P.R.E.=18 mmHg; 
P.L.E.=17 mmHg. M.R.I. Exam shows 
cerebral atrophy (Figure 2). 
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Figure 1 
Patient A.A., 51 years, with Steinert Myotonic 
Dystrophy 
 
 
Figure 2 
Patient A.A., 51 years, M.R.I. imagines shows 
cerebral atrophy 
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Figure 3 A, B 
Patient A.E., 58 years, with Steinert Myotonic 
Dystrophy 
 
Neurological examination shows motor 
disorders with central and peripheral 
causes. The biomicroscopy of the cataract 
indicates a favourable diagnosis (presence of 
iridescent crystals in the lens nucleus and 
cortex) and pathological neurological and 
neurosurgical associations. 
Differential Diagnosis: is made in 
relation to other pathological cataracts 
(diabetic, chronic eye inflammation, 
cortisone), senile cataract, traumatic 
cataract, persistent primary vitreous and 
Coats disease. 
Treatment 
Surgery was performed at LE: 
extracapsular lens extraction and 
implantation of the intraocular lens in the 
anterior chamber. 
Postoperative evolution with appropriate 
medical treatment was favourable. 
The evolution was favourable after 
surgery: the corneal edema resolved, the 
inflammatory syndrome healed, V.A.L.E. 
1/8 without correction. 
In the absence of surgical treatment, the 
prognosis is reserved, the disease 
progressing to peripheral blindness. 
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Case 2 
Patient A.E. 58 years, male,  from Iasi, 
presents the same clinical picture as in the 
previous case. The medical history shows: 
R.E. operated pathological cataract (10 years 
ago), O.U. Myogenic Bilateral Ptosis, 
Steinert Myotonic Dystrophy. Local ocular 
examination: O.U. Palpebral Ptosis grade 
2-3. The biomicroscopy highlights: R.E. 
Pseudophakia, L.E. full nucleus and cortex 
opacification, +3 nucleus sclerosis; 
polychromatic crystals are found in the lens 
nucleus and cortex (Figure 3 A, B). 
V.A.R.E. 1/500, V.A.L.E. less than 1/500, 
P.R.E.=17 mmHg; P.L.E.=16 mmHg. 
Ophthalmoscopic examination R.E.: net 
shape of optic nerve papilla, temporally 
pale, central emergence of narrow vessels 
macula with pigment dispersion;L.E. 
cannot be examined due to lens 
opacification. 
The internal medicine examination 
establishes the following diagnoses: 
Chronic Alcoholism, Chronic Ischemic 
Cardiomyopathy, Thrombocytopenia. 
M.R.I. Exam shows cerebral atrophy 
(Figure 4). 
 
 
Figure 4 
Patient A.E., 58 years M.R.I. 
imagines shows cerebral atrophy 
 
The neurological examination shows 
motor disorders with central and peripheral 
causes.The favourable diagnosis that 
emerges is: L.E. Pathological Cataract, R.E. 
Pseudophakia, O.U. Bilateral Myogenic 
Ptosis grade 2-3, Steinert Myotonic 
Dystrophy, Chronic Alcoholism, Chronic 
Ischemic Cardiomyopathy, 
Thrombocytopenia. The diagnosis of 
Pathological Cataract is supported by the 
muscle dystrophy and the particular aspect 
of the crystalline (presence of iridescent 
crystals in the lens nucleus and cortex). 
Differential Diagnosis: is made in 
relation to other pathological cataracts 
(diabetic, chronic eye inflammation, 
cortisone), senile cataract, traumatic 
cataract, persistent primary vitreous and 
Coats disease. 
Treatment 
Surgery was performed on L.E.: the 
phacoemulsification of the lens and 
implantation the intraocular lens in the 
posterior chamber with no intraoperative 
complications.The postoperative evolution 
under medical treatment was favorable. 
Evolution after surgery was favorable: 
inflammatory syndrome was completely 
resolved and V.A. at L.E. 1/3 without 
correction.The prognosis under surgical 
treatment is favorable. 
In the absence of surgical treatment, the 
prognosis is reserved, the disease 
progressing to peripheral blindness. 
Case particularity  
In the first case of pathological cataract 
due to the anterior and posterior capsule 
adhesion to the lens nucleus and cortex, a 
6-mm wide lens sclerocorneal incision was 
performed, with extracapsular lens 
extraction and pseudophak implantation in 
the anterior chamber.  
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The second case was solved by the 
method of phacoemulsification with clear 
corneal incision of 2.7 mm and pseudofak 
implantation in the posterior chamber. In 
both cases the cortex and nucleus were very 
dense and could cause posterior capsule 
rupture during surgery, resulting in the 
release of the vitreous and developing 
secondary glaucoma. In both cases the 
posterior capsule was very fragile presenting 
numerous cracks, and the intraocular lens 
was implanted in the anterior chamber.  
Discussions  
Eyes disorders in Steinert disease are 
common and are characterized mainly by 
pathological cataract. Other possible ocular 
manifestations are: myogenic ptosis, ocular 
hypotony due to ciliary body detachment 
(4) and reticular dystrophy of the retinal 
pigment epithelium, responsible for 
variable decrease in visual acuity (5). 
Gjertsen et al. report three cases diagnosed 
with myotonic dystrophy which developed 
secondary recurrent opacification of the 
posterior capsule after cataract surgery. 
These patients undergo an increased risk of 
posterior capsule opacification and 
intraocular fibrosis after cataract surgery 
(6). In the literature, for myogenic ptosis 
the treatment recommended is 
blepharoplasty or eyelid levator resection or 
frontalis muscle suspension. 
The eye disorder in our cases was 
pathological cataract and myogenic 
palpebral ptosis grade 2-3. Patients showed 
no significant ocular hypotony or retinal 
changes. We only solved surgically the 
pathological cataract and later remained to 
operate ptosis by upper eyelid levator 
resection. After operation there was no 
posterior capsule opacification. 
Conclusions 
Patients diagnosed with pathological 
cataract and Steinert Myotonic Dystrophy 
are advised to undergo cataract surgery, 
when there is no severe impairment of 
respiratory and cardiovascular systems and 
the surgical technique must be adapted to 
each case to minimize intraoperative and 
postoperative complications. Myogenic 
palpebral ptosis is recommended to be 
solved at a later stage. The long-term vision 
quality will depend on the progression of 
neurological damage, which adds to the 
retinal changes and brain damage (cerebral 
atrophy). 
References 
1.Lusakowska A., Sulek-Piatkowska A., Myotonic 
dystrophy – a new insight into a well-known disease. 
Neurol.Neurochir.Pol.-2010, 44(3):264-276. 
2.Debs R., Tiberge M., Troubles du sommeil et de la 
vigilance dans la maladie de Steinert, Sleep 
disturbancies in myotonic dystrophy type 1, Médecine 
du Sommeil- 2011, 8:141-144. 
3.American Academy of Ophthalmology, The Eye M.D. 
Association, Lens and Cataract, Printed in Singapore, 
Section 11, 2008-2009, 61. 
4.Rosa N., Lanza M., Borrelli M., De Bernardo 
M.,Palladino A., Di Gregorio M.G., Pascotto E., 
Politano I., Low intraocular pressure resulting fron 
ciliary body detachment in patients with myotonic 
dystrophy. Ophthalmology – 2011, 118(2):260-264. 
5. Tnacheri O., Birouk N., Benharbit M., Ibrahimy W., 
Laghmari M., Daoudi R., Rabat, Maroc, 520 Dystrophie 
réticulée de la macula et maladie de Steinert. Reticular 
macular dystrophy and Steinert disease.Journal Français 
d’Ophtalmologie-2008,31:165.  
6.Gjertsen I.K., Sandvig K.U., Eide N., Olsen B.A., 
Recurrence of secondary opacification and development 
of a dense posterior vitreous membrane in patients with 
myotonic dystrophy. J.Cataract.Retract.Surg.-2003, 
29(1):213-216. 
 
